Last updated: Sep 9, 2026, 12:00 AM

Starrag Group Holding AG Exchange (SW, CHF)

STGN.SW

35.50
+0.40 (+1.14%)
IndustrialsSpecialty Industrial Machinery
Invest Today
Invest Today
1 year return (CAGR)
9.91%
3 year return (CAGR)
-13.84%
5 year return (CAGR)
-3.58%
10 year return (CAGR)
-4.97%
Stock Analysis

Computer Modeling Group 2027 Q1 - Turnarounds seldom turn?

Read More
Marketcap
193.94M
Price/Sales
0.22
Ent value
366.39M
Price/Book
0.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
14.79%
Trailing P/E
18.15
PEG
-
Forward P/E
12.04
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open35.10
Daily high35.50
Daily low35.10
Daily Volume0K
All-time high88.00
1y analyst estimate45.00
Beta0.25
EPS (TTM)1.75
Dividend per share0.00
Ex-div date22 Apr 2026
Next earnings date-

Ready to capitalize on Starrag Group Holding AG's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
STGN.SWS&P500
Current price drop from All-time high-59.66%-0.99%
Highest price drop-71.43%-56.47%
Date of highest drop4 Jun 20049 Mar 2009
Avg drop from high-38.68%-10.69%
Avg time to new high134 days12 days
Max time to new high2746 days1805 days
News
BAYRY's sevabertinib wins first-line NSCLC approval. The company advances BAY 3670549 into a phase II AFib study.
September 10, 2026
The public limited liability company Invalda INVL (hereinafter – the Company) announces that on 10 September 2026 it redeemed all notes of the note issue ISIN LT0000409229. Noteholders were paid 100% ...
September 10, 2026
BBW, BBSI and BZZUF have been added to the Zacks Rank #5 (Strong Sell) List on September 10, 2026.
September 10, 2026
With a big redesign, will people still give their best? The answer depends on what you believe about your people.
September 10, 2026
WHIPPANY, N.J., September 10, 2026--U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated NSCLC
September 10, 2026
Sanoma Corporation, Stock Exchange Release, 9 September 2026 at 7:40 p.m. EET Sanoma Corporation: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market A...
September 9, 2026
LAVAL, France, September 09, 2026--Regulatory News: Séché Environnement (Paris:SCHP):
September 9, 2026
PRESS INFORMATIONHeading: 1st half 2026 results Nanterre, September 9, 2026 (after trading) 6.9% net profit in 1st half 2026 (in millions of euros)H1 20252025H1 2026 *Revenues424.3 857.2454.8Business ...
September 9, 2026
RESULTS for the 1st HALF OF 2026Turnover = €78.1M (-3.1%) EBITDA(1) = €6.2M (+21.4%)Equities = €63.2M (+7.0%) Blagnac, France, 9 September 2026, after closing of the Stock Market. SOGECLAIR, supplier ...
September 9, 2026
A leading property developer is quitting the housing market to cash in on soaring demand for data centres.
September 9, 2026